# Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

> **NCT00964457** · PHASE2 · UNKNOWN · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 60 (estimated)

## Conditions studied

- Rectum Cancer

## Interventions

- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00964457
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2012-07
- **Final completion:** 2017-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964457, "Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00964457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*